#ADCT ADC Therapeutics Announces New Employee Inducement Grant
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-new-employee-inducement-rya4cwl8owiq.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-new-employee-inducement-rya4cwl8owiq.html?utm_source=stocktitan-bluesky&utm_medium=social
www.stocktitan.net
November 2, 2026 at 9:05 PM
#ADCT ADC Therapeutics Announces New Employee Inducement Grant
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-new-employee-inducement-rya4cwl8owiq.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-new-employee-inducement-rya4cwl8owiq.html?utm_source=stocktitan-bluesky&utm_medium=social
#ADCT ADC Therapeutics to Announce Third Quarter 2026 Financial Results on November 9, 2026
https://www.stocktitan.net/news/ADCT/adc-therapeutics-to-announce-third-quarter-2026-financial-results-on-g260lyeeh4ui.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ADCT/adc-therapeutics-to-announce-third-quarter-2026-financial-results-on-g260lyeeh4ui.html?utm_source=stocktitan-bluesky&utm_medium=social
www.stocktitan.net
November 2, 2026 at 12:15 PM
#ADCT ADC Therapeutics to Announce Third Quarter 2026 Financial Results on November 9, 2026
https://www.stocktitan.net/news/ADCT/adc-therapeutics-to-announce-third-quarter-2026-financial-results-on-g260lyeeh4ui.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ADCT/adc-therapeutics-to-announce-third-quarter-2026-financial-results-on-g260lyeeh4ui.html?utm_source=stocktitan-bluesky&utm_medium=social
🚨 $ADCT
On November 4, 2026, ADC Therapeutics SA issued a press release and made available a presentation in connection with new and updated data from ZYNLONTA clinical trials which will be shared across multiple abstracts, including five oral presentations, at the 68 th American Society of Hemat...
On November 4, 2026, ADC Therapeutics SA issued a press release and made available a presentation in connection with new and updated data from ZYNLONTA clinical trials which will be shared across multiple abstracts, including five oral presentations, at the 68 th American Society of Hemat...
SEC Filing: ADCT
Click to view the official SEC document.
www.sec.gov
November 4, 2026 at 9:01 PM
🚨 $ADCT
On November 4, 2026, ADC Therapeutics SA issued a press release and made available a presentation in connection with new and updated data from ZYNLONTA clinical trials which will be shared across multiple abstracts, including five oral presentations, at the 68 th American Society of Hemat...
On November 4, 2026, ADC Therapeutics SA issued a press release and made available a presentation in connection with new and updated data from ZYNLONTA clinical trials which will be shared across multiple abstracts, including five oral presentations, at the 68 th American Society of Hemat...
ADC Therapeutics #$ADCT will present at two investor conferences in November.
Shares closed at $1.54 Mon: above SMA50, below SMA200, RSI 54.
Hub: www.merlintrader.com/adc-therapeu...
Not investment advice.
Shares closed at $1.54 Mon: above SMA50, below SMA200, RSI 54.
Hub: www.merlintrader.com/adc-therapeu...
Not investment advice.
ADCT Stock: ADC Therapeutics News, ZYNLONTA & LOTIS
ADC Therapeutics stock news: ZYNLONTA in Japan, LOTIS evidence, the conditional PIPE and royalty terms, with clinical and financing risks.
www.merlintrader.com
November 3, 2026 at 4:05 PM
ADC Therapeutics #$ADCT will present at two investor conferences in November.
Shares closed at $1.54 Mon: above SMA50, below SMA200, RSI 54.
Hub: www.merlintrader.com/adc-therapeu...
Not investment advice.
Shares closed at $1.54 Mon: above SMA50, below SMA200, RSI 54.
Hub: www.merlintrader.com/adc-therapeu...
Not investment advice.
#ADCT ADC Therapeutics Announces Abstracts at the 68th ASH Annual Meeting Highlighting Breadth of ZYNLONTA® Clinical Program
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-abstracts-at-the-68th-ash-annual-meeting-o7rkub9bhue9.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-abstracts-at-the-68th-ash-annual-meeting-o7rkub9bhue9.html?utm_source=stocktitan-bluesky&utm_medium=social
ADC Therapeutics Announces Abstracts at the 68th ASH Annual Meeting Highlighting Breadth of ZYNLONTA® Clinical Program
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
November 4, 2026 at 2:00 PM
#ADCT ADC Therapeutics Announces Abstracts at the 68th ASH Annual Meeting Highlighting Breadth of ZYNLONTA® Clinical Program
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-abstracts-at-the-68th-ash-annual-meeting-o7rkub9bhue9.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-abstracts-at-the-68th-ash-annual-meeting-o7rkub9bhue9.html?utm_source=stocktitan-bluesky&utm_medium=social
#ADCT ADC Therapeutics to Present at November Investor Conferences
https://www.stocktitan.net/news/ADCT/adc-therapeutics-to-present-at-november-investor-3du2ccw759qp.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ADCT/adc-therapeutics-to-present-at-november-investor-3du2ccw759qp.html?utm_source=stocktitan-bluesky&utm_medium=social
ADC Therapeutics to Present at November Investor Conferences
ADC Therapeutics (NYSE: ADCT) will participate in two November investor conferences, with Chief Executive Officer Ameet Mallik speaking in fireside chats. The Guggenheim conference is November 10, 2026, at 1:30 p.m. EST in Boston. The Jefferies conference is November 19, 2026, from 1–1:25 p.m. GMT in London. Live webcasts will be available on the company’s investor website, with replays available for approximately 30 days after each event.
www.stocktitan.net
November 3, 2026 at 12:15 PM
#ADCT ADC Therapeutics to Present at November Investor Conferences
https://www.stocktitan.net/news/ADCT/adc-therapeutics-to-present-at-november-investor-3du2ccw759qp.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ADCT/adc-therapeutics-to-present-at-november-investor-3du2ccw759qp.html?utm_source=stocktitan-bluesky&utm_medium=social
#$ADCT weekly close $1.53 (+6.2% w/w), above SMA50 $1.31 / below SMA200 $2.48, RSI 53.9. Support $1.11, resistance $1.87.
New hub updated: www.merlintrader.com/adc-therapeu...
New hub updated: www.merlintrader.com/adc-therapeu...
November 1, 2026 at 3:15 PM
#$ADCT weekly close $1.53 (+6.2% w/w), above SMA50 $1.31 / below SMA200 $2.48, RSI 53.9. Support $1.11, resistance $1.87.
New hub updated: www.merlintrader.com/adc-therapeu...
New hub updated: www.merlintrader.com/adc-therapeu...
ADC Therapeutics ($ADCT) – New 9.99% holder
• Holder: Bain Capital Life Sciences Opportunities IV
• Stake: 0 → 9.99% (about $24M)
• About 13G: a passive investor, not seeking to influence the company
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#Investing #Stocks
• Holder: Bain Capital Life Sciences Opportunities IV
• Stake: 0 → 9.99% (about $24M)
• About 13G: a passive investor, not seeking to influence the company
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#Investing #Stocks
Bain Capital Life Sciences Opportunities IV, LP: 9.99% of ADC Therapeutics ($ADCT)
Schedule 13G filed Oct 29. Who filed, the stake, and how it changed.
elixstocks.com
October 29, 2026 at 9:49 PM
ADC Therapeutics ($ADCT) – New 9.99% holder
• Holder: Bain Capital Life Sciences Opportunities IV
• Stake: 0 → 9.99% (about $24M)
• About 13G: a passive investor, not seeking to influence the company
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#Investing #Stocks
• Holder: Bain Capital Life Sciences Opportunities IV
• Stake: 0 → 9.99% (about $24M)
• About 13G: a passive investor, not seeking to influence the company
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#Investing #Stocks
#$ADCT Tanabe filed ZYNLONTA in Japan for r/r DLBCL + Nippon Shinyaku sublicense (filing, not approval).
Hub: www.merlintrader.com/adc-therapeu...
Chart: justcharts.merlintrader.com#ADCT
NFA
Hub: www.merlintrader.com/adc-therapeu...
Chart: justcharts.merlintrader.com#ADCT
NFA
October 29, 2026 at 2:27 PM
#$ADCT Tanabe filed ZYNLONTA in Japan for r/r DLBCL + Nippon Shinyaku sublicense (filing, not approval).
Hub: www.merlintrader.com/adc-therapeu...
Chart: justcharts.merlintrader.com#ADCT
NFA
Hub: www.merlintrader.com/adc-therapeu...
Chart: justcharts.merlintrader.com#ADCT
NFA
BUY_ON_CONFIRMATION $ADCT (ADCT.N) [Contract] @ 11:31:35Z
October 29, 2026 at 11:31 AM
BUY_ON_CONFIRMATION $ADCT (ADCT.N) [Contract] @ 11:31:35Z
#$ADCT Tanabe filed ZYNLONTA in Japan for r/r DLBCL + Nippon Shinyaku sublicense (filing, not approval).
Hub: www.merlintrader.com/adc-therapeu...
Chart: justcharts.merlintrader.com#ADCT
NFA
Hub: www.merlintrader.com/adc-therapeu...
Chart: justcharts.merlintrader.com#ADCT
NFA
October 29, 2026 at 2:27 PM
#$ADCT Tanabe filed ZYNLONTA in Japan for r/r DLBCL + Nippon Shinyaku sublicense (filing, not approval).
Hub: www.merlintrader.com/adc-therapeu...
Chart: justcharts.merlintrader.com#ADCT
NFA
Hub: www.merlintrader.com/adc-therapeu...
Chart: justcharts.merlintrader.com#ADCT
NFA
#ADCT ADC Therapeutics Announces ZYNLONTA® Updates in Japan
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-zynlonta-updates-in-uqbkvnnbh2bo.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-zynlonta-updates-in-uqbkvnnbh2bo.html?utm_source=stocktitan-bluesky&utm_medium=social
ADC Therapeutics Announces ZYNLONTA® Updates in Japan
ADC Therapeutics (ADCT) announced that partner Tanabe Pharma filed for Japanese approval of ZYNLONTA for previously treated diffuse large B-cell lymphoma.The application covers patients whose disease returned or resisted treatment after two or more lines of systemic therapy. In the Japanese Phase 2 study, the overall response rate was 58.1%, including a 41.9% complete response rate. Median response duration was not reached at a median follow-up of 15.21 months; no new safety concerns were identified.Tanabe Pharma also signed an exclusive commercialization sublicense with Nippon Shinyaku for Japan. ADC Therapeutics' existing license includes near-term milestones tied to application filing acceptance and the first commercial sale in the Tanabe Pharma territory.
www.stocktitan.net
October 29, 2026 at 11:30 AM
#ADCT ADC Therapeutics Announces ZYNLONTA® Updates in Japan
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-zynlonta-updates-in-uqbkvnnbh2bo.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-zynlonta-updates-in-uqbkvnnbh2bo.html?utm_source=stocktitan-bluesky&utm_medium=social
ADCT (ADCT) technical analysis: support, resistance, RSI, MACD, moving averages, and volume. Full breakdown at tickzen.app. Educational content only — not financial advice.
October 27, 2026 at 1:41 AM
ADCT (ADCT) technical analysis: support, resistance, RSI, MACD, moving averages, and volume. Full breakdown at tickzen.app. Educational content only — not financial advice.
Cresce pressão pelo adiamento da reforma tributária
Cresce pressão pelo adiamento da reforma tributária
Os prazos da reforma tributária estão no texto constitucional. Lê-se no artigo 126 do Ato das Disposições Constitucionais Transitórias (ADCT) ...
valor.globo.com
October 27, 2026 at 5:08 PM
Cresce pressão pelo adiamento da reforma tributária
🚨 HYPE ALERT: $ADCT (SOLANA)
📈 +3941.0% 1h · $363.4K vol 1h
💧 $30.6K liq · 1,193 holders
🎯 top-10 16% · 31 smart money
🔗 https://gmgn.ai/sol/token/HsbVYEPo3z5TJbPYZJ15dZDmpQXksJqgX5QSJnRwpump
📈 +3941.0% 1h · $363.4K vol 1h
💧 $30.6K liq · 1,193 holders
🎯 top-10 16% · 31 smart money
🔗 https://gmgn.ai/sol/token/HsbVYEPo3z5TJbPYZJ15dZDmpQXksJqgX5QSJnRwpump
October 23, 2026 at 5:29 PM
🚨 HYPE ALERT: $ADCT (SOLANA)
📈 +3941.0% 1h · $363.4K vol 1h
💧 $30.6K liq · 1,193 holders
🎯 top-10 16% · 31 smart money
🔗 https://gmgn.ai/sol/token/HsbVYEPo3z5TJbPYZJ15dZDmpQXksJqgX5QSJnRwpump
📈 +3941.0% 1h · $363.4K vol 1h
💧 $30.6K liq · 1,193 holders
🎯 top-10 16% · 31 smart money
🔗 https://gmgn.ai/sol/token/HsbVYEPo3z5TJbPYZJ15dZDmpQXksJqgX5QSJnRwpump
October 8, 2026: ADC Therapeutics announced an $86.6M private placement and a debt and royalty restructuring, runway into 2029. LOTIS-7 and MZL data due at ASH. $ADCT
https://www.merlintrader.com/adc-therapeutics-adct-stock-hub/
https://www.merlintrader.com/adc-therapeutics-adct-stock-hub/
ADC Therapeutics $ADCT: ZYNLONTA, Data And Dilution
ADC Therapeutics $ADCT stock hub: ZYNLONTA sales, LOTIS-5 FDA concerns, LOTIS-7 and MZL catalysts, conditional financing, royalties and dilution.
www.merlintrader.com
October 16, 2026 at 11:48 AM
October 8, 2026: ADC Therapeutics announced an $86.6M private placement and a debt and royalty restructuring, runway into 2029. LOTIS-7 and MZL data due at ASH. $ADCT
https://www.merlintrader.com/adc-therapeutics-adct-stock-hub/
https://www.merlintrader.com/adc-therapeutics-adct-stock-hub/
🚨 $ADCT
On October 8, 2026, the Company issued a press release that includes the preliminary net product revenues from sales of ZYNLONTA for the quarter ended September 30, 2026 and the preliminary cash and cash equivalents as of September 30, 2026. A copy of the press release is attached as Exhi...
On October 8, 2026, the Company issued a press release that includes the preliminary net product revenues from sales of ZYNLONTA for the quarter ended September 30, 2026 and the preliminary cash and cash equivalents as of September 30, 2026. A copy of the press release is attached as Exhi...
SEC Filing: ADCT
Click to view the official SEC document.
www.sec.gov
October 13, 2026 at 10:26 AM
🚨 $ADCT
On October 8, 2026, the Company issued a press release that includes the preliminary net product revenues from sales of ZYNLONTA for the quarter ended September 30, 2026 and the preliminary cash and cash equivalents as of September 30, 2026. A copy of the press release is attached as Exhi...
On October 8, 2026, the Company issued a press release that includes the preliminary net product revenues from sales of ZYNLONTA for the quarter ended September 30, 2026 and the preliminary cash and cash equivalents as of September 30, 2026. A copy of the press release is attached as Exhi...
$SXTC fell 88% after $12M offering at $1.50/share with high dilution risk. 30-day option for more. Details & more biotech news on BioPharmCatalyst. $PCRX $SBFM $ADCT $CYCN
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
Daily Updates 10/08/26
export-download.canva.com
October 8, 2026 at 8:30 PM
$SXTC fell 88% after $12M offering at $1.50/share with high dilution risk. 30-day option for more. Details & more biotech news on BioPharmCatalyst. $PCRX $SBFM $ADCT $CYCN
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
#ADCT ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-comprehensive-strategic-financial-dty6tk4zw1p7.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-comprehensive-strategic-financial-dty6tk4zw1p7.html?utm_source=stocktitan-bluesky&utm_medium=social
ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
October 8, 2026 at 1:00 PM
#ADCT ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-comprehensive-strategic-financial-dty6tk4zw1p7.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ADCT/adc-therapeutics-announces-comprehensive-strategic-financial-dty6tk4zw1p7.html?utm_source=stocktitan-bluesky&utm_medium=social
E pensar que é meio estranho a PEC ter o mesmo poder do poder constituinte originário, só fizeram uma revisão constitucional e foi isso por causa do ADCT, mesmo podendo haver a possibilidade de revisão constitucional igual minha professora de constitucional defendia...
September 9, 2026 at 7:39 PM
E pensar que é meio estranho a PEC ter o mesmo poder do poder constituinte originário, só fizeram uma revisão constitucional e foi isso por causa do ADCT, mesmo podendo haver a possibilidade de revisão constitucional igual minha professora de constitucional defendia...
👀 Most people order pizza the same way every time. But there's a little-known trick that could score you something extra without spending more. Would you try it?
🎥 See the hack: www.youtube.com/shorts/-adct...
🎥 See the hack: www.youtube.com/shorts/-adct...
How to Get FREE Cake & Best Pizza Hack! 🍰🍕 #Shorts
Mark your calendars for September 15th! 🗓️ Over 800 Nothing Bundt Cakes locations are giving away 300 free bundtlets per store. Plus, we're sharing a must-visit pizza spot near the Cleveland…
www.youtube.com
September 8, 2026 at 10:00 AM
👀 Most people order pizza the same way every time. But there's a little-known trick that could score you something extra without spending more. Would you try it?
🎥 See the hack: www.youtube.com/shorts/-adct...
🎥 See the hack: www.youtube.com/shorts/-adct...
#ADCT ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
https://www.stocktitan.net/news/ADCT/adc-therapeutics-to-participate-in-the-2026-cantor-global-healthcare-f8ln198q1zlo.html
https://www.stocktitan.net/news/ADCT/adc-therapeutics-to-participate-in-the-2026-cantor-global-healthcare-f8ln198q1zlo.html
A CEO will join a healthcare fireside chat. The event will be webcast Sept. 11.
Ameet Mallik will participate in New York at 9:10 a.m. ET, with a live webcast and replay available for approximately 30 days.
www.stocktitan.net
September 3, 2026 at 11:15 AM
#ADCT ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
https://www.stocktitan.net/news/ADCT/adc-therapeutics-to-participate-in-the-2026-cantor-global-healthcare-f8ln198q1zlo.html
https://www.stocktitan.net/news/ADCT/adc-therapeutics-to-participate-in-the-2026-cantor-global-healthcare-f8ln198q1zlo.html
